Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma × gedatolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Uterine Neoplasms 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Carboplatin 6 pembrolizumab 4 Sorafenib 3 Pemetrexed 3 Paclitaxel 3 Gemcitabine 3 Cyclophosphamide 3 seocalcitol 2 selinexor 2 patritumab 2 osimertinib 2 liposomal doxorubicin 2 interferon gamma-1b 2 fludarabine 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Irinotecan 2 Interleukin-2 2 Erlotinib Hydrochloride 2 DNA 2 Cisplatin 2 Celecoxib 2 Capecitabine 2 Bleomycin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 volociximab 1 thioredoxin reductase inhibitor AM12 1 sonidegib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02920450 2019-10-04

UF-STO-LUNG-002

University of Florida

Phase 1/2 Terminated

3 enrolled 8 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡